ProCE Banner Activity

Estudios principales de VIH que influyeron en mi práctica después de CROI 2022

Slideset Download
Lea los resúmenes de un panel de expertos de los estudios clave sobre el VIH de CROI 2022, incluidos los resultados de los estudios de estrategias de prevención, terapias de acción prolongada, tratamientos de segunda línea, comorbilidades y cura.

Released: March 18, 2022

Expiration: March 17, 2023

No longer available for credit.

Share

Faculty

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Daniel R. Kuritzkes

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

David Alain Wohl

David Alain Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

La Dra. Monica Gandhi, MPH, no tiene conflictos de interés relevantes de los que informar.

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

El Dr. Daniel R. Kuritzkes ha informado haber recibido fondos de ayuda a la investigación de Gilead Sciences, Merck y ViiV Healthcare y honorarios de consulta de Abpro, Atea, Decoy, Gilead Sciences, GlaxoSmithKline, Janssen, Merck y ViroStatics.

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS, ha revelado que ha recibido honorarios por consultoría de Gilead Sciences, Merck y ViiV Healthcare/GSK y fondos de contratistas independientes de Johnson & Johnson.

David Alain Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

El Dr. David A. Wohl ha revelado haber recibido fondos para apoyo a la investigación de Gilead Sciences y Merck y honorarios de consultoría de Gilead Sciences, Janssen, Merck y ViiV.